Blog
Moderna Stock Jumps After FDA Reverses Course on Flu Shot
Shares of Moderna MRNA rose 6% on Wednesday after the company announced that the FDA agreed to review its regulatory filing seeking approval for its seasonal influenza vaccine, mRNA-1010. A final
Edison International Q4 Earnings Top Estimates, Sales Increase Y/Y
Edison International EIX reported fourth-quarter 2025 adjusted earnings of $1.87 per share, which surpassed the Zacks Consensus Estimate of $1.47 by 27.4%. The bottom line also increased 78.1% from
CRH's Q4 Earnings Meet Estimates, Revenues Up Y/Y, Stock Down
CRH plc CRH delivered mixed fourth-quarter 2025 results, with adjusted earnings meeting the Zacks Consensus Estimate and increasing on a year-over-year basis. Total revenues missed the consensus
Nordson's Earnings Surpass Estimates in Q1, Revenues Up Y/Y
Nordson Corporation’s NDSN first-quarter fiscal 2026 (ended Jan. 31, 2026) adjusted earnings of $2.37 per share surpassed the Zacks Consensus Estimate of $2.36. The bottom line increased 15% year
Can Aris Mining Sustain Margin Momentum Amid Cost Pressures?
Aris Mining Corporation ARMN has been subject to rising operating costs over time. In third-quarter 2025, the company’s all-in-sustaining costs (AISC) per ounce, a crucial indicator of cost
Alcoa's Alumina Segment Growth Picks Up: More Upside to Come?
Alcoa Corporation AA is benefiting from persistent strength in its Alumina segment, supported by strong performances across its assets and favorable prices. The segment is benefiting from growth in
ONE Gas Q4 Earnings Beat Estimates, Revenues Increase Y/Y
ONE Gas, Inc. OGS reported fourth quarter 2025 operating earnings per share (EPS) of $1.48, which beat the Zacks Consensus Estimate of $1.42 by 4%. In the year-ago quarter, the company reported
Pfizer Targets Long-Term Oncology Growth Amid Competitive Pressure
Pfizer PFE is one of the largest and most successful drugmakers in oncology with an established presence in breast, genitourinary, thoracic, gastrointestinal cancer and blood cancers. It boasts a
Should You Bet on South Korea ETFs After the Kospi Rally?
Kospi, South Korea’s benchmark index, hit an all-time high above 5,600 on Thursday, after gaining about 3.09% in a single trading session. South Korea remains one of Asia’s most lucrative markets
Oil Index ETF (OILT) Touches New 52-Week High
For investors seeking momentum, the Texas Capital Texas Oil Index ETF OILT is probably on the radar now. The fund just hit a 52-week high and is up 50.5% from its 52-week low price of $18.22 per
CenterPoint Energy Q4 Earnings Lag Estimates, Revenues Rise Y/Y
CenterPoint Energy, Inc. CNP reported fourth-quarter 2025 adjusted earnings of 45 cents per share, which missed the Zacks Consensus Estimate of 46 cents by 1.1%. However, the bottom line increased
ETFs in Spotlight as Trump Moves to Mobilize Defense Production Act
On Feb. 18, 2026, U.S. President Donald Trump signed a landmark executive order invoking the Defense Production Act (DPA) to secure the domestic supply of elemental phosphorus and glyphosate-based
Omnicom's Q4 Earnings and Revenues Miss Estimates, Increase Y/Y
Omnicom OMC reported unimpressive fourth-quarter 2025 results, with both earnings and revenues missing the Zacks Consensus Estimate.
OMC’s earnings were $2.59 per share, missing the Zacks Consensus
Papa John's (PZZA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
The market expects Papa John's (PZZA) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus
Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: Should You Buy?
Rhythm Pharmaceuticals, Inc. (RYTM) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known
Analysts Estimate United Parks & Resorts (PRKS) to Report a Decline in Earnings: What to Look Out for
The market expects United Parks & Resorts (PRKS) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known
Will NovoCure (NVCR) Report Negative Earnings Next Week? What You Should Know
The market expects NovoCure (NVCR) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus
PENN Entertainment (PENN) Expected to Beat Earnings Estimates: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when PENN Entertainment (PENN) reports results for the quarter ended December 2025. While this widely-known consensus
Earnings Preview: Perrigo (PRGO) Q4 Earnings Expected to Decline
The market expects Perrigo (PRGO) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook
NetApp (NTAP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when NetApp (NTAP) reports results for the quarter ended January 2026. While this widely-known consensus outlook is
nLight (LASR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when nLight (LASR) reports results for the quarter ended December 2025. While this widely-known consensus outlook is
Intuit (INTU) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Intuit (INTU) reports results for the quarter ended January 2026. While this widely-known consensus outlook is
Nexa Resources S.A. (NEXA) Earnings Expected to Grow: Should You Buy?
The market expects Nexa Resources S.A. (NEXA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known
Monster Beverage (MNST) Earnings Expected to Grow: Should You Buy?
Monster Beverage (MNST) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus
Krispy Kreme (DNUT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Krispy Kreme (DNUT) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook


